Rentschler Biotechnologie and Rentschler Fill Solutions Partner on Fill/Finish
PTSM: Pharmaceutical Technology Sourcing and Management
The companies are partnering to provide new fill/finish facilities and solutions for biopharmaceutical products.
On June 13, 2017, Rentschler Biotechnologie GmbH and Rentschler Fill Solutions GmbH announced a strategic partnership to provide new fill/finish facilities and solutions for biopharmaceutical products. Under the terms of the agreement, Rentschler Fill Solutions will serve as the exclusive partner for the fill/finish services of Rentschler Biotechnologie’s manufacturing projects. Rentschler Fill Solutions is owned by the Rentschler family and will begin operations in mid-2018. In addition to servicing Rentschler Biotechnologie’s clients, Rentschler Fill Solutions will offer its fill/finish services on a clinical as well as commercial scale to its own client base.
The company will employ advanced aseptic filling technology at the Rentschler Fill Solutions facility in Austria. The filling technology will be able to fill up to 60,000 vials per batch. Timelines and batch sizes can be tailored and flexibly scaled. The Rentschler Fill Solutions facility complies with all required regulatory standards and is designed to enable future expansion without interrupting ongoing operations.
Rentschler Biotechnologie and Rentschler Fill Solutions will introduce their partnership and service offering at the BIO International Convention from June 19–22 in San Diego, CA.
Source: Rentschler
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.
